Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 2/20 | 0.30 |
| ▸ | NPY1R | P25929 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10102398 | 0.95 | MAPT (0.34) | MAPT | |
| SCHEMBL26032649 | 0.93 | AKT1 (0.34) | MAPT | |
| SCHEMBL10102279 | 0.92 | MAPT (0.32) | MAPT | |
| SCHEMBL15763601 | 0.89 | MAPT (0.34) | MAPT | |
| SCHEMBL10102281 | 0.89 | MAPT (0.31) | MAPT | |
| SCHEMBL10102284 | 0.89 | PDK2 (0.30) | — | |
| SCHEMBL14617526 | 0.89 | PDK2 (0.30) | — | |
| SCHEMBL22864324 | 0.88 | ATM (0.34) | MAPT | |
| SCHEMBL27393177 | 0.88 | AKT1 (0.34) | MAPT | |
| SCHEMBL25954005 | 0.88 | POLB (0.32) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240241291-A1 | FUNCTIONAL LAMINATE AND FUNCTIONAL LENS COMPRISING THE FUNCTIONAL LAMINATE | TOKUYAMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20230272252-A1 | ADHESIVE COMPOSITION, LAMINATE AND OPTICAL ARTICLE COMPRISING THE LAMINATE | TOKUYAMA CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230260669-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | TOKUYAMA CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4183579-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | Tokuyama Corporation (JP) | 2023-05-24 | — | — | EP | disclosed |
| US-20200386915-A1 | FUNCTIONAL LAMINATE AND FUNCTIONAL LENS COMPRISING THE FUNCTIONAL LAMINATE | TOKUYAMA CORPORATION (JP) | 2020-12-10 | — | — | US | disclosed |
| EP-3495441-B1 | ADHESIVE COMPOSITION, LAMINATE, AND OPTICAL ARTICLE INCLUDING SAID LAMINATE | TOKUYAMA CORP (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-20200283662-A1 | ADHESIVE COMPOSITION, LAMINATE AND OPTICAL ARTICLE COMPRISING THE LAMINATE | TOKUYAMA CORPORATION (JP) | 2020-09-10 | — | — | US | disclosed |
| US-10690943-B2 | Laminate and optical article comprising the same | TOKUYAMA CORPORATION (JP) | 2020-06-23 | — | — | US | disclosed |
| EP-2602300-B1 | PHOTOCHROMIC COMPOSITION | TOKUYAMA CORP (JP) | 2019-06-12 | — | — | EP | disclosed |
| US-20190004336-A1 | LAMINATE AND OPTICAL ARTICLE COMPRISING THE SAME | TOKUYAMA CORPORATION (JP) | 2019-01-03 | — | — | US | disclosed |
| EP-2602300-A1 | PHOTOCHROMIC COMPOSITION | Tokuyama Corporation (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-8308995-B2 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2012-11-13 | — | — | US | disclosed |
| EP-2275418-B1 | CHROMENE COMPOUND | TOKUYAMA CORP (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-20120138876-A1 | CHROMENE COMPOUND | KASAI SOKO (JP) | 2012-06-07 | — | — | US | disclosed |
| US-8147726-B2 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| EP-2377902-A1 | COATING COMPOSITION, PROCESS FOR PRODUCTION OF THE COMPOSITION, AND LAMINATE WITH HARD COAT LAYER | Tokuyama Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-20110244244-A1 | COATING COMPOSITION, PROCESS FOR PRODUCING THE COMPOSITION, AND LAMINATE HAVING A HARD COAT LAYER | TOKUYAMA CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110244244-A1 | COATING COMPOSITION, PROCESS FOR PRODUCING THE COMPOSITION, AND LAMINATE HAVING A HARD COAT LAYER | TOKUYAMA CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110062396-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| EP-2275418-A1 | CHROMENE COMPOUND | Tokuyama Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120138876-A1 | CHROMENE COMPOUND | CHRM1, CBX8, CBX7 | MAPT 3134/4885MAOB 1895/4885AVPR1A 1443/4885 |
| US-20110062396-A1 | CHROMENE COMPOUND | CDYL, NR0B1, NR1H2 | MAPT 4740/4885MAOB 1845/4885AVPR1A 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.